SCHOTT Pharma provides drug containment and delivery solutions for the pharmaceutical and biotech industries, self-described as offering a scientifically proven product portfolio for the safe storage and administration of injectable drugs.

SCHOTT Pharma

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

HSTS

DoubleClick.Net

US Privacy User Signal Mechanism

Member of the GP Supervisory Board

Jens Schulte

Marketing and Product

Christopher Hauke

Head of Supply Chain Management

Flavia Painelli

Sales Executive

Neil Wilcock

Head of Laboratory Chemical Analysis

Alexander Filippi

Manager Information Technology R&D, Production and Quality

Alexander Koch

Head of Regional Operations Europe Bulk Solutions

Balazs Vizi

Senior Area Sales Manager

Brigitte LECHIFFRE

Pricing Excellence Manager

Bruno Azevedo

Business Development Manager

Chen Chen

Wolfgang Wienand

Health Care Companies With More Than 1000 Employees (Top 10K)

Europe Companies With More Than $100M in Revenue (Top 10K)

Europe Companies With More Than 1000 Employees (Top 10K)

Biotechnology Companies With More Than $10M in Revenue

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. 

SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules.

The company has focused on developing innovations for future technologies by: 
•	Creating over 900 patents and technologies developed in-house
•	Building a state-of-the-art Research and Development Center in Switzerland
•	Absorbing over 130 professionals focused on Research and Development

Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation.

SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 821 million in the fiscal year 2022.

Mainz

Rheinland-Pfalz

Germany

Europe

Gerresheimer, Stevanato Group and SCHOTT Pharma Announce...

Promotion for SCHOTT Pharma: Listed on the MDAX for the first time

Berenberg rates Schott Pharma as 'Hold' - Target 32 euros

Schott Pharma raises sales forecast after good quarter

SCHOTT Pharma delivers strong third quarter results and r...

Schott Pharma recovers - confirmation of annual targets is well received

SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024

Schott Pharma expands production capacity with new Lukácsháza facility

Schott Pharma warns of weak syringe sales - share price slide

Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight'

United States

North America

Taiwan

Asia

India

Brazil

South America

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 4:47 PM	6282248e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 4:47 PM	0f7d94b7
crunchbase trigger	general	Oct 28, 2024 1:50 PM	a8059f1f
crunchbase profile	general	Oct 28, 2024 9:45 PM	5a0240a2
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	87f7b5b7
peers	general	Sep 27, 2024 4:47 PM	358eafd1
news basic	general	Sep 27, 2024 4:47 PM	eba5345a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:SCHOTT-PHARMA

SCHOTT Pharma